HER2/NEU NEGATIVE
Clinical trials for HER2/NEU NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU NEGATIVE trials appear
Sign up with your email to follow new studies for HER2/NEU NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could breast cancer patients avoid surgery? new trial tests less treatment
Disease control Recruiting nowThis study is for people with certain types of breast cancer (HER2-positive or triple-negative) who have a complete response to initial drug therapy. It tests whether they can safely skip surgery and only receive radiation, or skip radiation if surgery shows no cancer left. For a…
Matched conditions: HER2/NEU NEGATIVE
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can new drug combos outsmart PARP resistance in BRCA breast cancer?
Disease control Recruiting nowThis phase 2 trial tests whether adding cediranib or ceralasertib to olaparib can overcome resistance in BRCA-mutated advanced breast cancer. About 60 participants with HER2-negative, BRCA-positive tumors that have progressed on prior therapy will receive one of the two drug comb…
Matched conditions: HER2/NEU NEGATIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Blood test monitoring may be as good as scans for breast cancer patients
Knowledge-focused Recruiting nowThis study is testing whether using simple blood tests to decide when to do scans is as effective as the usual approach of regular scans for people with advanced breast cancer. About 739 participants will be randomly assigned to either blood test monitoring or standard care. The …
Matched conditions: HER2/NEU NEGATIVE
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC